Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rousseau MC et al. – This study confirms that, under VPA treatment, hyperammonaemia is a current event; 25.4% patients presented isolated elevated ammonaemia when receiving VPA for very long durations. VPA therapy should be monitored closely and clinicians must be warned of VPA encephalopathy signs.

Related Articles

Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid
Clinical Infectious Diseases, 11/16/09    Relevance Score: 66%

Direct hepatic differentiation of embryonic stem cells induced by valproic acid and cytokines
World Journal of Gastroenterology, 11/12/09    Relevance Score: 64%

Risk factors for valproic acid resistance in childhood absence epilepsy
Seizure - European Journal of Epilepsy, 10/21/09    Relevance Score: 64%

Multiple organ dysfunction syndrome: infection or hypersensitivity reaction
European Journal of Emergency Medicine, 10/12/09    Relevance Score: 64%

Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells
British Journal of Haematology, 10/08/09    Relevance Score: 64%

Today in Neuro/Psych pharmacology...keeping you current

Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/10/09

Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
Multiple Sclerosis, 12/10/09

Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address